Cir­ius with­draws $86M IPO as vaunt­ed 'Year of NASH' draws to bru­tal close

Cir­ius Ther­a­peu­tics didn’t wait for the gov­ern­ment shut­down to end be­fore it filed its IPO in Jan­u­ary. It was, as JP Mor­gan an­a­lysts had pre­dict­ed the month pri­or, “The Year of NASH” and Cir­ius be­lieved their Phase II pro­gram could raise $86 mil­lion.

To­day, eleven months and a slew of in­dus­try-wide NASH fail­ures lat­er, Cir­ius is with­draw­ing their IPO. The news adds per­haps 2019’s fi­nal nail in ex­pec­ta­tions that were first buried months ago.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.